Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2764122rdf:typepubmed:Citationlld:pubmed
pubmed-article:2764122lifeskim:mentionsumls-concept:C0001443lld:lifeskim
pubmed-article:2764122lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2764122lifeskim:mentionsumls-concept:C2256468lld:lifeskim
pubmed-article:2764122lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2764122lifeskim:mentionsumls-concept:C0441712lld:lifeskim
pubmed-article:2764122pubmed:issue2 Pt 2lld:pubmed
pubmed-article:2764122pubmed:dateCreated1989-9-14lld:pubmed
pubmed-article:2764122pubmed:abstractTextTo evaluate further the role of adenosine in the transmission of tubuloglomerular feedback signals, we studied the effects of an adenosine receptor antagonist and an adenosine A1-receptor agonist on feedback-mediated changes in stop-flow pressure (SFP). In orthograde perfusion experiments conducted in anesthetized rats, systemic administration of the adenosine receptor blocker 1,3-dipropyl-8-sulfophenylxanthine (PSPX) did not inhibit feedback responses. Control SFP feedback responses averaged 9.7 +/- 0.65 before and 8.6 +/- 0.55 mmHg during systemic infusion of the receptor blocker. In retrograde perfusion experiments, intratubular administration of the A1 agonist (360 nM) N6-cyclopentyladenosine (CPA), added to a hypotonic solution, markedly enhanced feedback responses. This effect was completely prevented by coinfusion of PSPX. Addition of 10 mM of the antagonist to the CPA-containing solution attenuated SFP feedback responses to less than 1 mmHg (delta = 0.44 +/- 0.50). Furthermore, PSPX also inhibited feedback responses obtained with an isotonic solution alone. Furosemide, which has been shown to block normal SFP responses obtained with isotonic solutions, failed to block CPA-induced decreases in SFP. These data demonstrate that intraluminal administration of an adenosine A1 analogue causes feedback-mediated decreases in SFP and therefore support a role for adenosine receptors in the signal transmission pathway.lld:pubmed
pubmed-article:2764122pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:languageenglld:pubmed
pubmed-article:2764122pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:citationSubsetIMlld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2764122pubmed:statusMEDLINElld:pubmed
pubmed-article:2764122pubmed:monthAuglld:pubmed
pubmed-article:2764122pubmed:issn0002-9513lld:pubmed
pubmed-article:2764122pubmed:authorpubmed-author:FrancoMMlld:pubmed
pubmed-article:2764122pubmed:authorpubmed-author:NavarL GLGlld:pubmed
pubmed-article:2764122pubmed:authorpubmed-author:BellP DPDlld:pubmed
pubmed-article:2764122pubmed:issnTypePrintlld:pubmed
pubmed-article:2764122pubmed:volume257lld:pubmed
pubmed-article:2764122pubmed:ownerNLMlld:pubmed
pubmed-article:2764122pubmed:authorsCompleteYlld:pubmed
pubmed-article:2764122pubmed:paginationF231-6lld:pubmed
pubmed-article:2764122pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:meshHeadingpubmed-meshheading:2764122-...lld:pubmed
pubmed-article:2764122pubmed:year1989lld:pubmed
pubmed-article:2764122pubmed:articleTitleEffect of adenosine A1 analogue on tubuloglomerular feedback mechanism.lld:pubmed
pubmed-article:2764122pubmed:affiliationDepartment of Physiology and Biophysics, University of Alabama, Birmingham 35294.lld:pubmed
pubmed-article:2764122pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2764122pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2764122pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2764122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2764122lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2764122lld:pubmed